Literature DB >> 15255799

Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation.

Ruth Fricker1, Christiane Hesse, Johanna Weiss, Yorki Tayrouz, Michael M Hoffmann, Kristina Unnebrink, Ulrich Mansmann, Walter E Haefeli.   

Abstract

AIMS: Polymorphisms of the NOSIII gene and of the CYBA gene have been associated with a number of pathological conditions such as arterial hypertension, coronary artery disease, and myocardial infarction. Because endothelium-dependent vasodilation is impaired in these disorders, we hypothesized that polymorphisms of NOSIII or CYBA might modulate endothelial function of venous capacitance vessels already before cardiovascular disease becomes overt.
METHODS: Endothelium-dependent and -independent venodilation was assessed by measuring local vascular responses to bradykinin and sodium nitroprusside in the dorsal hand vein after preconstriction with phenylephrine in 72 healthy male Caucasians after careful exclusion of cardiovascular risk factors. Genotyping was performed for polymorphisms of the NOSIII gene (T-786C, G894T, (CA)(n)) and the CYBA gene (C242T).
RESULTS: Genotype distribution for each polymorphism followed the Hardy-Weinberg equilibrium. In all studied single nucleotide polymorphisms no significant difference between the respective genotypes and the venodilator response to either sodium nitroprusside or bradykinin was observed, and the number of CA repeat copies was not related to the venodilator response to bradykinin. Mean venodilation induced by bradykinin 50 ng min(-1) (+/-SEM) for homozygote carriers of the single nucleotide polymorphisms was 48.9 +/- 8.5% venodilation (G894T; wild type: 49.8 +/- 6.9), 50.3 +/- 11.0% venodilation (T-786C; wild type: 42.6 +/- 5.2), and 30.4 +/- 9.1% venodilation (C242T; wild type: 49.2 +/- 6.0), respectively.
CONCLUSIONS: This study suggests that the studied polymorphisms of NOSIII and CYBA do not significantly modulate endothelium-dependent venodilation in individuals without vascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255799      PMCID: PMC1884579          DOI: 10.1111/j.1365-2125.2004.02130.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  39 in total

1.  Lack of evidence for association of high altitude pulmonary edema and polymorphisms of the NO pathway.

Authors:  Johanna Weiss; Walter Emil Haefeli; Christiane Gasse; Michael Marcus Hoffmann; Jörn Weyman; Simon Gibbs; Ulrich Mansmann; Peter Bärtsch
Journal:  High Alt Med Biol       Date:  2003       Impact factor: 1.981

2.  Heterogeneity in hand veins responses to acetylcholine is not associated with polymorphisms in the G-protein beta3-subunit (C825T) and endothelial nitric oxide synthase (G894T) genes but with serum low density lipoprotein cholesterol.

Authors:  M Grossmann; D Dobrev; W Siffert; W Kirch
Journal:  Pharmacogenetics       Date:  2001-06

3.  Combined effects of endothelial nitric oxide synthase gene polymorphism (G894T) and insulin resistance status on blood pressure and familial risk of hypertension in young adults: the Bogalusa Heart Study.

Authors:  W Chen; S R Srinivasan; A Elkasabany; D L Ellsworth; E Boerwinkle; G S Berenson
Journal:  Am J Hypertens       Date:  2001-10       Impact factor: 2.689

4.  In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism.

Authors:  G Sofowora; V Dishy; H G Xie; H Imamura; Y Nishimi; C R Morales; J D Morrow; R B Kim; C M Stein; A J Wood
Journal:  Pharmacogenetics       Date:  2001-12

5.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

6.  Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase.

Authors:  M P Schneider; J Erdmann; C Delles; E Fleck; V Regitz-Zagrosek; R E Schmieder
Journal:  J Hypertens       Date:  2000-12       Impact factor: 4.844

7.  T-786C polymorphism in endothelial NO synthase gene affects cerebral circulation in smokers: possible gene-environmental interaction.

Authors:  Shampa Nasreen; Toru Nabika; Hiroshi Shibata; Hidehiko Moriyama; Kazuya Yamashita; Junichi Masuda; Shotai Kobayashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

8.  Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: The Suita Study.

Authors:  Y Tsujita; S Baba; R Yamauchi; T Mannami; M Kinoshita; R Yamamoto; T Katsuya; J Higaki; T Ogihara; J Ogata; N Iwai
Journal:  J Hypertens       Date:  2001-11       Impact factor: 4.844

9.  Rapid detection of polymorphisms of the nitric oxide cascade.

Authors:  Johanna Weiss; Ruth Fricker; Walter E Haefeli
Journal:  Clin Chem Lab Med       Date:  2002-04       Impact factor: 3.694

10.  Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function.

Authors:  C P M Leeson; A D Hingorani; M J Mullen; N Jeerooburkhan; M Kattenhorn; T J Cole; D P R Muller; A Lucas; S E Humphries; J E Deanfield
Journal:  Circ Res       Date:  2002-06-14       Impact factor: 17.367

View more
  6 in total

1.  Subclinical atherosclerosis and vascular stiffness in premenopausal women: association with NOS3 and CYBA polymorphisms.

Authors:  Irene Lambrinoudaki; Panagiota Chatzivasileiou; Stefanos Stergiotis; Eleni Armeni; Dimitrios Rizos; George Kaparos; Areti Augoulea; Andreas Alexandrou; Georgios Georgiopoulos; Aggeliki Laina; Kimon Stamatelopoulos
Journal:  Heart Vessels       Date:  2018-06-09       Impact factor: 2.037

2.  Kinetics and dynamics of the peripheral neurokinin-1 receptor antagonist SLV317 in healthy individuals.

Authors:  Christiane Hesse; Steffen P Luntz; Heike Siedler; Kristina Unnebrink; Gerd Mikus; Marianne de Bruijn; Edu Zondag; Michiel de Vries; Monika Seibert-Grafe; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2006-04       Impact factor: 4.335

3.  Association of endothelial nitric oxide synthase gene polymorphisms with classical risk factors in development of premature coronary artery disease.

Authors:  T A Abdel-Aziz; R H Mohamed
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

4.  Smoking dose modifies the association between C242T polymorphism and prevalence of metabolic syndrome in a Chinese population.

Authors:  Jiyong Ge; Zhijian Ding; Yu Song; Fangfang Wang
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

5.  No difference in genotype frequencies of polymorphisms of the nitric oxide pathway between Caucasian normal and high tension glaucoma patients.

Authors:  Johanna Weiss; Stephan A Fränkl; Josef Flammer; Matthias C Grieshaber; Gabor Hollo; Barbara Teuchner; Walter Emil Haefeli
Journal:  Mol Vis       Date:  2012-08-07       Impact factor: 2.367

Review 6.  Genetic Regulation of Endothelial Vasomotor Function.

Authors:  Seung Kyum Kim; Michael P Massett
Journal:  Front Physiol       Date:  2016-11-25       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.